Authors:
Johansen, O
Abdelnoor, M
Brekke, M
Seljeflot, I
Hostmark, AT
Arnesen, H
Citation: O. Johansen et al., Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables, SC CARDIOVA, 35(2), 2001, pp. 86-91
Authors:
Hurlen, M
Hole, T
Seljeflot, I
Arnesen, H
Citation: M. Hurlen et al., Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction, EUR J HE FA, 3(2), 2001, pp. 203-207
Authors:
Guzic-Salobir, B
Keber, I
Seljeflot, I
Arnesen, H
Vrabic, L
Citation: B. Guzic-salobir et al., Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women, J INTERN M, 250(6), 2001, pp. 508-515
Authors:
Schumacher, A
Lerkerod, AB
Seljeflot, I
Sommervoll, L
Holme, I
Otterstad, JE
Arnesen, H
Citation: A. Schumacher et al., Chlamydia pneumoniae serology: Importance of methodology in patients with coronary heart disease and healthy individuals, J CLIN MICR, 39(5), 2001, pp. 1859-1864
Authors:
Solheim, S
Seljeflot, I
Arnesen, H
Eritsland, J
Eikvar, L
Citation: S. Solheim et al., Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks, ATHEROSCLER, 157(2), 2001, pp. 411-415
Authors:
Seljeflot, I
Arnesen, H
Hofstad, AE
Os, I
Citation: I. Seljeflot et al., Reduced expression of endothelial cell markers after long-term transdermalhormone replacement therapy in women with coronary artery disease, THROMB HAEM, 83(6), 2000, pp. 944-948
Citation: M. Hurlen et al., Increased platelet aggregability during exercise in patients with previousmyocardial infarction, lack of inhibition by aspirin, THROMB RES, 99(5), 2000, pp. 487-494
Authors:
Hoibraaten, E
Os, I
Seljeflot, I
Andersen, TO
Hofstad, AE
Sandset, PM
Citation: E. Hoibraaten et al., The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: Results from the estrogen in women with atherosclerosis study, THROMB RES, 98(1), 2000, pp. 19-27
Authors:
Johansen, O
Seljeflot, I
Hostmark, AT
Arensen, H
Citation: O. Johansen et al., The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease, ART THROM V, 19(7), 1999, pp. 1681-1686
Authors:
Johansen, O
Brekke, M
Seljeflot, I
Abdelnoor, M
Arnesen, H
Citation: O. Johansen et al., n-3 fatty acids do not prevent restenosis after coronary angioplasty: Results from the CART study, J AM COL C, 33(6), 1999, pp. 1619-1626
Authors:
Seljeflot, I
Johansen, O
Arnesen, H
Eggesbo, JB
Westvik, AB
Kierulf, P
Citation: I. Seljeflot et al., Procoagulant activity and cytokine expression in whole blood cultures frompatients with atherosclerosis supplemented with omega-3 fatty acids, THROMB HAEM, 81(4), 1999, pp. 566-570
Authors:
Seljeflot, I
Arnesen, H
Andersen, P
Aspelin, T
Kierulf, P
Citation: I. Seljeflot et al., Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men, J CARDIO PH, 34(4), 1999, pp. 584-588
Authors:
Brude, IR
Finstad, HS
Seljeflot, I
Drevon, CA
Solvoll, K
Sandstad, B
Hjermann, I
Arnesen, H
Nenseter, MS
Citation: Ir. Brude et al., Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers, EUR J CL IN, 29(2), 1999, pp. 100-108
Authors:
Stromme, JH
Johansen, O
Brekke, M
Seljeflot, I
Arnesen, H
Citation: Jh. Stromme et al., Markers of myocardial injury in blood following PTCA: A comparison of CKMB, cardiospecific troponin T and troponin I, SC J CL INV, 58(8), 1998, pp. 693-699